amphetamine has been researched along with nisoxetine in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Izenwasser, S; Kornetsky, C | 1 |
Snoddy, AM; Tessel, RE | 2 |
Li, J; Ordway, GA; Shamburger, S; Zhu, MY | 1 |
Gnegy, M; Kantor, L; Park, YH; Wang, KK | 1 |
Ma, Q; Spealman, RD; Xu, TX; Yao, WD | 1 |
Desai, A; Fraser, R; Gnegy, ME; Guptaroy, B; Zhang, M | 1 |
8 other study(ies) available for amphetamine and nisoxetine
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Potentiation of morphine analgesia by D-amphetamine is mediated by norepinephrine and not dopamine.
Topics: Amphetamine; Analgesics; Animals; Dopamine; Dopamine Antagonists; Drug Synergism; Electric Stimulation; Escape Reaction; Fluoxetine; Morphine; Nalidixic Acid; Naphthyridines; Norepinephrine; Pain; Reaction Time; Reticular Formation | 1988 |
Prazosin: effect on psychomotor-stimulant cues and locomotor activity in mice.
Topics: Amphetamine; Animals; Cocaine; Cues; Discrimination, Psychological; Fluoxetine; Male; Mice; Mice, Inbred ICR; Motor Activity; Pimozide; Prazosin; Propranolol; Stereotyped Behavior | 1985 |
Nisoxetine and amphetamine share discriminative stimulus properties in mice.
Topics: Amphetamine; Animals; Discrimination, Psychological; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fluoxetine; Male; Mice; Mice, Inbred ICR; Premedication; Propylamines; Taste | 1983 |
Regulation of the human norepinephrine transporter by cocaine and amphetamine.
Topics: Amphetamine; Animals; Carrier Proteins; Cells, Cultured; Cocaine; Fluoxetine; Humans; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; PC12 Cells; Rats; RNA, Messenger; Symporters | 2000 |
Enhanced amphetamine-mediated dopamine release develops in PC12 cells after repeated amphetamine treatment.
Topics: Amphetamine; Animals; Dopamine; Fluoxetine; Nerve Growth Factor; PC12 Cells; Rats | 2002 |
Amphetamine modulation of long-term potentiation in the prefrontal cortex: dose dependency, monoaminergic contributions, and paradoxical rescue in hyperdopaminergic mutant.
Topics: Amphetamine; Animals; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Fluoxetine; Long-Term Potentiation; Mice; Mice, Inbred C57BL; Mice, Knockout; Mutation; Norepinephrine; Prefrontal Cortex; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2 | 2010 |
Site-directed mutations near transmembrane domain 1 alter conformation and function of norepinephrine and dopamine transporters.
Topics: Amphetamine; Benztropine; Binding Sites; Biotinylation; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Fluoxetine; HEK293 Cells; Humans; Immunoblotting; Mutagenesis, Site-Directed; Norepinephrine Plasma Membrane Transport Proteins; Pharmacokinetics; Protein Conformation | 2011 |